Mangoceuticals, Inc. announced the expansion of its men's health product line with the addition of its hair growth treatment, ?Grow. The custom compounded hair growth treatment combines four clinically proven hair growth products - Minoxidil, Finasteride, Vitamin D3, and Biotin - encapsulated in convenient chewable, mint-flavored tablets. The product is now available for delivery by prescription through MangoRx's website.

Grow's unique compounded formula combines Minoxidil, which encourages blood flow and follicle development, with Finasteride, blocking the formation of DHT (a known cause of male pattern baldness), along with supplements Vitamin D3, slowing hair-follicle calcification, and Biotin, which plays a crucial role in healthy hair growth. When combined, the four clinically proven hair growth products work to promote new growth in three to six months. According to the American Hair Loss Association, by the age of 35 two-thirds of American men will experience some degree of increased hair loss, and by the age of 50, approximately 85% of men have significantly thinning hair.

The process of male pattern baldness can begin before the age of 21 for approximately 25% of men. Interested consumers can use MangoRx's telemedicine platform for a smooth medical prescription that is exclusively compounded for each individual. Orders will then be reviewed by a physician and, if approved, fulfilled and discreetly shipped through MangoRx's partner compounding pharmacy and right to the patient's doorstep.